Paroxetine
Paroxetine Price range: $ 44,00 through $ 321,00
Back to products
Penegra
Penegra Price range: $ 43,00 through $ 1 134,00

Paxil

Price range: $ 34,00 through $ 445,00

Paxil is a well-established medication in the selective serotonin reuptake inhibitor (SSRI) class designed to help balance brain chemistry. It is primarily utilized for the treatment of major depressive disorder and various forms of chronic anxiety. Patients often use this treatment to manage symptoms associated with panic disorder, social anxiety disorder, and generalized anxiety disorder. Additionally, it is an effective option for individuals dealing with obsessive-compulsive disorder and post-traumatic stress disorder. By regulating serotonin levels, Paxil helps improve mood, sleep quality, and energy levels for those facing these mental health challenges.

Active substance: paroxetine
SKU: Paxil Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Paxil belongs to a class of medications known as selective serotonin reuptake inhibitors (SSRIs). It is a prescription-only drug evaluated and approved by the US Food and Drug Administration (FDA) for managing several major psychiatric conditions in adult patients.

Because individual metabolic responses vary, therapy with paroxetine hydrochloride must be initiated and monitored by a qualified healthcare professional who can determine proper dosage adjustments and evaluate ongoing clinical efficacy.

Basic Clinical Overview

Parameter Details
Active Ingredient Paroxetine hydrochloride
Therapeutic Class Selective Serotonin Reuptake Inhibitor (SSRI)
Route of Administration Oral (tablets, oral suspension)
Primary Purpose Treatment of major depressive and anxiety disorders
Prescription Status Prescription only (Rx)
Mechanism Summary Inhibition of presynaptic serotonin reuptake in the CNS

How the drug works

Paxil exerts its therapeutic effect primarily through the potent and selective inhibition of the neuronal reuptake of serotonin (5-hydroxytryptamine, or 5-HT). By binding to the sodium-dependent serotonin transporter (SERT) at the presynaptic membrane, paroxetine prevents the clearance of serotonin from the synaptic cleft. This leads to an enhancement of serotonergic neurotransmission within the central nervous system. Paroxetine exhibits significantly lower affinity for adrenergic (alpha-1, alpha-2, beta), dopamine (D2), and histaminergic (H1) receptors compared to classic tricyclic antidepressants, although it possesses weak muscarinic acetylcholine receptor affinity relative to other SSRIs.

Main uses

The FDA has approved Paxil for several specific psychiatric indications in adults. These labeled indications include Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), Panic Disorder (PD) with or without agoraphobia, Social Anxiety Disorder (SAD), Generalized Anxiety Disorder (GAD), and Posttraumatic Stress Disorder (PTSD). Each of these conditions requires tailored dosing strategies. Off-label uses–which represent clinical applications not explicitly approved by the FDA–include the management of premature ejaculation and the symptomatic relief of hot flashes associated with menopause.

Dosing schedule

Paxil is administered orally, typically as a single daily dose in the morning to minimize nocturnal sleep disturbances. In the treatment of Major Depressive Disorder, the standard starting dose is 20 mg/day, which may be increased in increments of 10 mg/day at weekly intervals up to a maximum of 50 mg/day based on clinical response. For Panic Disorder and OCD, initial doses often start lower (10 mg/day or 20 mg/day) and can be titrated up to a maximum of 60 mg/day. Dosing protocols must be individualized, and lower initial doses (typically 10 mg/day) are recommended for elderly patients, as well as individuals with severe hepatic or renal impairment.

How it’s absorbed and eliminated

Paroxetine hydrochloride is well absorbed from the gastrointestinal tract following oral administration. It undergoes extensive first-pass hepatic metabolism, principally via the cytochrome P450 enzyme CYP2D6. Because paroxetine acts as a potent inhibitor of its own metabolic pathway (CYP2D6 autoinhibition), its pharmacokinetics are non-linear at higher doses or following prolonged administration. The elimination half-life of paroxetine is approximately 21 hours (with an observed range generally between 15 and 24 hours). Steady-state plasma concentrations are typically achieved within 7 to 14 days after starting therapy or changing dosages.

What not to combine

Co-administration of Paxil with Monoamine Oxidase Inhibitors (MAOIs) is strictly contraindicated due to the severe risk of Serotonin Syndrome, a potentially life-threatening condition; a minimum 14-day washout period is required when switching between an MAOI and paroxetine. Concomitant use with thioridazine or pimozide is also contraindicated due to potential QT interval prolongation and cardiac arrhythmias. Caution is required when combining Paxil with nonsteroidal anti-inflammatory drugs (NSAIDs), aspirin, or warfarin, as serotonin reuptake inhibition impairs platelet aggregation and increases the risk of upper gastrointestinal bleeding. Additionally, drugs that inhibit or are metabolized by CYP2D6, such as tamoxifen or atomoxetine, require careful medical assessment before concurrent use.

Adverse reactions

Common adverse reactions associated with Paxil therapy include nausea, somnolence, sweating, tremor, dry mouth, asthenia, dizziness, constipation, reduced appetite, and sexual dysfunction (such as delayed ejaculation, erectile dysfunction, or decreased libido). Less common but clinically significant risks include serotonin syndrome, hyponatremia (primarily due to the syndrome of inappropriate antidiuretic hormone secretion, SIADH, particularly in elderly patients), activation of mania or hypomania in susceptible individuals, bone fractures, angle-closure glaucoma, and abnormal bleeding events.

Important precautions

Paxil carries an FDA Boxed Warning regarding an increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults (up to age 24) during initial treatment. Clinical monitoring for worsening depression, emergent suicidality, or sudden behavioral changes is essential during the early weeks of therapy. Abrupt discontinuation of paroxetine is associated with a high incidence of discontinuation syndrome (characterized by dizziness, sensory disturbances such as paresthesias or “brain zaps,” anxiety, nausea, and vivid dreams); therefore, medication must be gradually tapered under direct medical supervision. Paroxetine exposure during the first trimester of pregnancy has been linked to an increased risk of congenital cardiovascular malformations, necessitating a thorough risk-benefit assessment for female patients of childbearing potential.

First days of treatment

During the initial 1 to 2 weeks of Paxil administration, patients may experience mild gastrointestinal side effects, minor headache, or temporary changes in sleep architecture. These early side effects often diminish over time as the body adapts to the medication. Therapeutic antidepressant or anxiolytic effects are rarely immediate; clinically significant improvements usually take 4 to 6 weeks of continuous daily use to fully manifest.

Signs of improvement

Evaluation of treatment response relies on monitoring cumulative changes over several weeks. Patients may first notice improvements in neurovegetative symptoms, such as stabilization of sleep patterns, appetite normalization, or increased physical energy, prior to a marked improvement in overall mood or reduction in anxiety symptoms. Ongoing assessment by the prescribing healthcare provider helps determine whether the current dosage is appropriate or requires adjustment.

Food and alcohol interactions

Paxil may be ingested with or without food. Taking the tablet with meals may help attenuate initial gastrointestinal distress, such as nausea. Consumption of alcoholic beverages should be avoided during treatment with paroxetine, as alcohol can potentiate central nervous system depression, impairment of motor skills, and drowsiness induced by the medication.

If you skip a dose

If a dose of Paxil is missed, it should be taken as soon as remembered on the same day. However, if it is nearly time for the next scheduled dose, the missed dose should be skipped and the regular schedule resumed. Patients must not double the dose to make up for a missed tablet. Maintaining consistent daily timing helps maintain stable blood concentrations and reduces the likelihood of withdrawal-like symptoms.

Frequently Asked Questions

Why must Paxil be tapered slowly rather than stopped abruptly?

Abrupt cessation of paroxetine can trigger SSRI discontinuation syndrome. Because paroxetine has a relatively short elimination half-life (approximately 21 hours) and lacks active metabolites, rapid drops in serum concentration frequently cause symptoms such as dizziness, sensory paresthesias (electric shock sensations), irritability, headache, and nausea. A gradual dose reduction schedule designed by a physician helps the central nervous system adjust safely.

Can Paxil be taken alongside common over-the-counter pain relievers?

Caution is necessary when combining Paxil with nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or naproxen, as well as aspirin. Selective serotonin reuptake inhibitors reduce platelet serotonin levels, which affects blood clotting. Combining these medications increases the statistical risk of gastrointestinal bleeding. Patients should consult their prescriber or pharmacist for recommended pain relief alternatives.

How does Paxil differ from other medications in the SSRI class?

While all SSRIs share a primary mechanism of serotonin transporter inhibition, paroxetine displays higher potency at the SERT site and possesses slight anticholinergic activity compared to agents like fluoxetine or sertraline. Furthermore, paroxetine undergoes non-linear pharmacokinetics due to its inhibition of CYP2D6, resulting in a higher propensity for discontinuation symptoms if doses are missed.

What steps should be taken if early treatment causes severe restlessness?

Some patients may experience akathisia–a state of inner restlessness, agitation, or inability to remain still–shortly after starting Paxil or following a dose increase. If these symptoms develop, the patient should contact their prescribing provider promptly. A clinician can evaluate the condition, adjust the titration schedule, or alter the therapeutic strategy if necessary.

In accordance with FDA guidelines and official prescribing information.

The information presented here is not a substitute for professional medical advice. Always consult your healthcare provider before starting or changing any treatment.

Additional information
Dosage

10 mg

,

20mg

,

30mg

,

40mg

Package

30 pills

,

60 pills

,

90 pills

,

120 pills

,

180 pills

,

270 pills

,

360 pills

Ενεργός Ουσία